Search Results - "Haznedaroğlu, Ibrahim C"

Increased mean platelet volume (MPV) indicating the vascular risk in Alzheimer's disease (AD) by Yesil, Yusuf, Kuyumcu, Mehmet Emin, Cankurtaran, Mustafa, Uz, Burak, Kara, Atilla, Kilic, Mustafa Kemal, Halil, Meltem, Ulger, Zekeriya, Yavuz, Burcu Balam, Haznedaroğlu, Ibrahim C, Ariogul, Servet

“…Abstract Vascular risk factors play a significant role in the pathogenesis and progression of AD. MPV is an index of platelet activation and may be a potential…”
Get full text

Current management of chronic myeloid leukemia with tyrosine kinase inhibitors by Haznedaroğlu, Ibrahim C

“…The clinical outcomes and survival of tyrosine kinase inhibitor (TKI)-treated patients with chronic myeloid leukemia (CML) have been significantly improved…”
Get full text

Increased soluble selectins as a reflection of activated platelets and endothelium in Legg-Calve-Perthes disease by Ismayilov, Vusal, Aksoy, Duygu Yazgan, Sayinalp, Nilgun, Haznedaroğlu, Ibrahim C, Aksoy, Mehmet Cemalettin

“…Legg-Calve-Perthes disease (LCPD) is still an enigma. Hemostatic abnormalities have been indicated in the pathogenesis. We had previously demonstrated enhanced…”
Get full text

The effects of blood group types on the risk of COVID-19 infection and its clinical outcome by Göker, Hakan, Aladağ Karakulak, Elifcan, Demiroğlu, Haluk, Ayaz Ceylan, Çağlayan Merve, Büyükaşik, Yahya, Inkaya, Ahmet Çağkan, Aksu, Salih, Sayinalp, Nilgün, Haznedaroğlu, Ibrahim Celalettin, Uzun, Ömrüm, Akova, Murat, Özcebe, Osman Ilhami, Ünal, Serhat

“…COVID-19 (Coronavirus disease of 2019) is an infectious disease outbreak later on declared as a pandemic, caused by the SARS-CoV-2 (severe acute respiratory…”
Get full text

Pathologic thrombopoiesis of rheumatoid arthritis by ERTENLI, Ihsan, KIRAZ, Sedat, ÖZTÜRK, M. Akif, HAZNEDAROGLU, Ibrahim C, CELIK, Ismail, CALGÜNERI, Meral

“…Rheumatoid arthritis (RA) is frequently complicated by thrombocytosis correlated with disease activity. The exact pathogenetic mechanism(s) that cause…”
Get full text

Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis by Haznedaroglu, Ibrahim C, Beyazit, Yavuz

“…The locally active ligand peptides, mediators, receptors and signalling pathways of the haematopoietic BM (bone marrow) autocrine/paracrine RAS…”
Get more information

Immunogenomic phases of COVID-19 and appropriate clinical management by Haznedaroglu, Ibrahim C

Get full text

Nilotinib-Associated Multiple Silent Arterial Stenoses in a Patient with Chronic Myeloid Leukemia by Tokatlı, Mert, Ismayilov, Rashad, Erkin Çınar, Olgu, Haznedaroğlu, İbrahim C.

Get full text

WHO 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors by Haznedaroğlu, İbrahim C., Kuzu, Işınsu, İlhan, Osman

“…Philadelphia (Ph*)/BCR-ABL1-positive chronic myeloid leukemia (CML) is considered as a chronic life-long disease, which could be manageable with tyrosine…”
Get full text

Increased factor VIII level lends diversity to ischemic stroke etiology by Erol, Ozlem, Kara, Gamze, Ozçakar, Levent, Haznedaroglu, Ibrahim C

Get more information

Branch retinal vein occlusion associated with platelet activation by BEYAZYILDIZ, Emrullah, ÇITIRIK, Mehmet, ŞIMŞEK, Mert, BEYAZYILDIZ, Özlem, C. HAZNEDAROĞLU, İbrahim

Get full text

COVID-19, Renin-Angiotensin System, and Hematopoiesis by Çiftçiler, Rafiye, Haznedaroğlu, İbrahim C.

“…We had initially indicated that there is a local hematopoietic bone marrow (BM) renin-angiotensin system (RAS), active in the physiological and pathological…”
Get full text

Drug Therapy in the Progressed CML Patient with multi-TKI Failure by Haznedaroglu, Ibrahim C

“…The aim of this paper is to outline pharmacotherapy of the 'third-line management of CML' (progressive disease course after sequential TKI drugs). Current…”
Get full text

Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance by ÇİFTÇİLER, Rafiye, KOLUMAN, Ahmet, C. HAZNEDAROĞLU, İbrahim, AKAR, Nejat

Get full text

The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine by Okay, Mufide, Ozturk, Yusuf, Haznedaroglu, Ibrahim C.

Get full text

Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper) by Ciftciler, Rafiye, Ciftciler, Ali Erdinc, Malkan, Umit Yavuz, Haznedaroglu, Ibrahim C

“…Ankaferd hemostat (Ankaferd blood stopper [ABS], Istanbul, Turkey) is a hemostatic agent affecting red blood cell-fibrinogen interactions. ABS has been…”
Get full text

Ankaferd hemostat in the management of gastrointestinal hemorrhages by Beyazit, Yavuz, Kekilli, Murat, Haznedaroglu, Ibrahim C, Kayacetin, Ertugrul, Basaranoglu, Metin

“…Gastrointestinal （GI） bleeding refers to any hemorrhage ascribed to the pathologies of the gastrointestinal tract,extending from the mouth to the anal…”
Get full text

Review: Pathobiological aspects of the local bone marrow renin-angiotensin system: a review by Haznedaroglu, Ibrahim C, Beyazit, Yavuz

“…The local haematopoietic bone marrow (BM) renin—angiotensin system (RAS) mediates pathobiological alterations of haematopoiesis in an…”
Get full text

Discontinuation of imatinib mesylate could improve renal impairment in chronic myeloid leukemia by Malkan, Umit Y., Haznedaroglu, Ibrahim C.

“…We aim to report a CML case that had fluid retention and serum creatinine increase under long-term imatinib mesylate (IM) treatment. A 68-year-old woman was…”
Get full text

Monitoring the Response to Tyrosine Kinase Inhibitor (TKI) Treatment in Chronic Myeloid Leukemia (CML) by Haznedaroglu, Ibrahim C

“…The aim of oral tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML) is to get ideal hematological, cytogenetic, molecular responses at…”
Get full text